{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:32:54Z","timestamp":1794346374514,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1125-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:06:50Z","timestamp":1522800410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge"],"prefix":"10.1186","volume":"15","author":[{"given":"Hallel C.","family":"Paraiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Chang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Curfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Sweazey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-Lei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-9888","authenticated-orcid":false,"given":"I-Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.neuroscience.2008.07.031","volume":"158","author":"JL Teeling","year":"2009","unstructured":"Teeling JL, Perry VH. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience. 2009;158:1062\u201373.","journal-title":"Neuroscience"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","volume":"13","author":"CN Widmann","year":"2014","unstructured":"Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13:630\u20136.","journal-title":"Lancet Neurol"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443\u201351.","journal-title":"JAMA"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","volume":"383","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383:911\u201322.","journal-title":"Lancet"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","volume":"292","author":"K Yaffe","year":"2004","unstructured":"Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292:2237\u201342.","journal-title":"JAMA"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopsych.2008.04.016","volume":"64","author":"AL Marsland","year":"2008","unstructured":"Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry. 2008;64:484\u201390.","journal-title":"Biol Psychiatry"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.it.2015.08.003","volume":"36","author":"A Shemer","year":"2015","unstructured":"Shemer A, Erny D, Jung S, Prinz M. Microglia plasticity during health and disease: an immunological perspective. Trends Immunol. 2015;36:614\u201324.","journal-title":"Trends Immunol"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest. 2012;122:1164\u201371.","journal-title":"J Clin Invest"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"208093","DOI":"10.1155\/2013\/208093","volume":"2013","author":"T Goldmann","year":"2013","unstructured":"Goldmann T, Prinz M. Role of microglia in CNS autoimmunity. Clin Dev Immunol. 2013;2013:208093.","journal-title":"Clin Dev Immunol"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014;10:217\u201324.","journal-title":"Nat Rev Neurol"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0190-9622(94)70121-0","volume":"30","author":"PJ Altmeyer","year":"1994","unstructured":"Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G, et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol. 1994;30:977\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molmed.2004.11.003","volume":"11","author":"U Mrowietz","year":"2005","unstructured":"Mrowietz U, Asadullah K. Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med. 2005;11:43\u20138.","journal-title":"Trends Mol Med"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012;367:1087\u201397.","journal-title":"N Engl J Med"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012;367:1098\u2013107.","journal-title":"N Engl J Med"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11910-013-0394-8","volume":"13","author":"RA Linker","year":"2013","unstructured":"Linker RA, Gold R. Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects. Curr Neurol Neurosci Rep. 2013;13:394.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011;134:678\u201392.","journal-title":"Brain"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/jpet.111.190132","volume":"341","author":"RH Scannevin","year":"2012","unstructured":"Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther. 2012;341:274\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1172\/JCI72151","volume":"124","author":"H Chen","year":"2014","unstructured":"Chen H, Assmann JC, Krenz A, Rahman M, Grimm M, Karsten CM, Kohl J, Offermanns S, Wettschureck N, Schwaninger M. Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate\u2019s protective effect in EAE. J Clin Invest. 2014;124:2188\u201392.","journal-title":"J Clin Invest"},{"key":"1125_CR19","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1073\/pnas.1603907113","volume":"113","author":"U Schulze-Topphoff","year":"2016","unstructured":"Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA, Cree BA, Sobel RA, Wipke BT, Steinman L, et al. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proc Natl Acad Sci U S A. 2016;113:4777\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","volume":"65","author":"P Giannetti","year":"2014","unstructured":"Giannetti P, Politis M, Su P, Turkheimer F, Malik O, Keihaninejad S, Wu K, Reynolds R, Nicholas R, Piccini P. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study. Neurobiol Dis. 2014;65:203\u201310.","journal-title":"Neurobiol Dis"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12975-017-0543-5","volume":"8","author":"IC Yu","year":"2017","unstructured":"Yu IC, Kuo PC, Yen JH, Paraiso HC, Curfman ET, Hong-Goka BC, Sweazey RD, Chang FL. A combination of three repurposed drugs administered at reperfusion as a promising therapy for postischemic brain injury. Transl Stroke Res. 2017;8:560\u201377.","journal-title":"Transl Stroke Res"},{"key":"1125_CR22","doi-asserted-by":"publisher","unstructured":"Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013;(71). \n                    https:\/\/doi.org\/10.3791\/50079\n                    \n                  .","DOI":"10.3791\/50079"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-016-0733-1","volume":"13","author":"R Lin","year":"2016","unstructured":"Lin R, Cai J, Kostuk EW, Rosenwasser R, Iacovitti L. Fumarate modulates the immune\/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation. 2016;13:269.","journal-title":"J Neuroinflammation"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12975-016-0496-0","volume":"7","author":"Y Yao","year":"2016","unstructured":"Yao Y, Miao W, Liu Z, Han W, Shi K, Shen Y, Li H, Liu Q, Fu Y, Huang D, Shi FD. Dimethyl fumarate and monomethyl fumarate promote post-ischemic recovery in mice. Transl Stroke Res. 2016;7:535\u201347.","journal-title":"Transl Stroke Res"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbi.2017.01.018","volume":"62","author":"PC Kuo","year":"2017","unstructured":"Kuo PC, Yu IC, Scofield BA, Brown DA, Curfman ET, Paraiso HC, Chang FL, Yen JH. 3H-1,2-Dithiole-3-thione as a novel therapeutic agent for the treatment of ischemic stroke through Nrf2 defense pathway. Brain Behav Immun. 2017;62:180\u201392.","journal-title":"Brain Behav Immun"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","volume":"20","author":"ME Witte","year":"2014","unstructured":"Witte ME, Mahad DJ, Lassmann H, van Horssen J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med. 2014;20:179\u201387.","journal-title":"Trends Mol Med"},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nlm.2013.06.014","volume":"105","author":"SJ Moore","year":"2013","unstructured":"Moore SJ, Deshpande K, Stinnett GS, Seasholtz AF, Murphy GG. Conversion of short-term to long-term memory in the novel object recognition paradigm. Neurobiol Learn Mem. 2013;105:174\u201385.","journal-title":"Neurobiol Learn Mem"},{"key":"1125_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"1125_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acn3.270","volume":"3","author":"MA Michell-Robinson","year":"2016","unstructured":"Michell-Robinson MA, Moore CS, Healy LM, Osso LA, Zorko N, Grouza V, Touil H, Poliquin-Lasnier L, Trudelle AM, Giacomini PS, et al. Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. Ann Clin Transl Neurol. 2016;3:27\u201341.","journal-title":"Ann Clin Transl Neurol"},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1742-2094-7-30","volume":"7","author":"H Wilms","year":"2010","unstructured":"Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U, Lucius R. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation. 2010;7:30.","journal-title":"J Neuroinflammation"},{"key":"1125_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneuroim.2016.08.006","volume":"299","author":"H Peng","year":"2016","unstructured":"Peng H, Li H, Sheehy A, Cullen P, Allaire N, Scannevin RH. Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments. J Neuroimmunol. 2016;299:35\u201344.","journal-title":"J Neuroimmunol"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-017-0829-2","volume":"14","author":"B Ambrosius","year":"2017","unstructured":"Ambrosius B, Faissner S, Guse K, von Lehe M, Grunwald T, Gold R, Grewe B, Chan A. Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. J Neuroinflammation. 2017;14:51.","journal-title":"J Neuroinflammation"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-016-0559-x","volume":"13","author":"R Han","year":"2016","unstructured":"Han R, Xiao J, Zhai H, Hao J. Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2\/hemoxygenase-1 pathway by altering the balance of M1\/M2 macrophages. J Neuroinflammation. 2016;13:97.","journal-title":"J Neuroinflammation"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-9-151","volume":"9","author":"D Krstic","year":"2012","unstructured":"Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C, et al. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation. 2012;9:151.","journal-title":"J Neuroinflammation"},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/brain\/awn101","volume":"131","author":"MC Pott Godoy","year":"2008","unstructured":"Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain. 2008;131:1880\u201394.","journal-title":"Brain"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","volume":"25","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. IL-1 receptor\/toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun. 2011;25:1281\u20139.","journal-title":"Brain Behav Immun"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12035-014-8868-5","volume":"52","author":"CA Moraes","year":"2015","unstructured":"Moraes CA, Santos G, de Sampaio e Spohr TC, D'A vila JC, Lima FR, Benjamim CF, Bozza FA, Gomes FC. Activated microglia-induced deficits in excitatory synapses through IL-1beta: implications for cognitive impairment in sepsis. Mol Neurobiol. 2015;52:653\u201363.","journal-title":"Mol Neurobiol"},{"key":"1125_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbi.2009.10.002","volume":"24","author":"AM Hein","year":"2010","unstructured":"Hein AM, Stasko MR, Matousek SB, Scott-McKean JJ, Maier SF, Olschowka JA, Costa AC, O'Banion MK. Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav Immun. 2010;24:243\u201353.","journal-title":"Brain Behav Immun"},{"key":"1125_CR40","doi-asserted-by":"publisher","first-page":"12470","DOI":"10.1523\/JNEUROSCI.0542-14.2014","volume":"34","author":"J Czerniawski","year":"2014","unstructured":"Czerniawski J, Guzowski JF. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus. J Neurosci. 2014;34:12470\u201380.","journal-title":"J Neurosci"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbi.2014.09.014","volume":"44","author":"J Czerniawski","year":"2015","unstructured":"Czerniawski J, Miyashita T, Lewandowski G, Guzowski JF. Systemic lipopolysaccharide administration impairs retrieval of context-object discrimination, but not spatial, memory: evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation. Brain Behav Immun. 2015;44:159\u201366.","journal-title":"Brain Behav Immun"},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1089\/ars.2015.6622","volume":"24","author":"MS Brennan","year":"2016","unstructured":"Brennan MS, Patel H, Allaire N, Thai A, Cullen P, Ryan S, Lukashev M, Bista P, Huang R, Rhodes KJ, Scannevin RH. Pharmacodynamics of dimethyl fumarate are tissue specific and involve NRF2-dependent and -independent mechanisms. Antioxid Redox Signal. 2016;24:1058\u201371.","journal-title":"Antioxid Redox Signal"},{"key":"1125_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2015.04.006","volume":"283","author":"GO Gillard","year":"2015","unstructured":"Gillard GO, Collette B, Anderson J, Chao J, Scannevin RH, Huss DJ, Fontenot JD. DMF, but not other fumarates, inhibits NF-kappaB activity in vitro in an Nrf2-independent manner. J Neuroimmunol. 2015;283:74\u201385.","journal-title":"J Neuroimmunol"},{"key":"1125_CR44","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.1101712","volume":"188","author":"CE Rockwell","year":"2012","unstructured":"Rockwell CE, Zhang M, Fields PE, Klaassen CD. Th2 skewing by activation of Nrf2 in CD4(+) T cells. J Immunol. 2012;188:1630\u20137.","journal-title":"J Immunol"},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","volume":"76","author":"W Li","year":"2008","unstructured":"Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol. 2008;76:1485\u20139.","journal-title":"Biochem Pharmacol"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.4049\/jimmunol.172.6.3553","volume":"172","author":"MP Soares","year":"2004","unstructured":"Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004;172:3553\u201363.","journal-title":"J Immunol"},{"key":"1125_CR47","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1038\/srep03242","volume":"3","author":"YJ Hwang","year":"2013","unstructured":"Hwang YJ, Lee EW, Song J, Kim HR, Jun YC, Hwang KA. MafK positively regulates NF-kappaB activity by enhancing CBP-mediated p65 acetylation. Sci Rep. 2013;3:3242.","journal-title":"Sci Rep"},{"key":"1125_CR48","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1523\/JNEUROSCI.2745-14.2015","volume":"35","author":"E Hennessy","year":"2015","unstructured":"Hennessy E, Griffin EW, Cunningham C. Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1beta and TNF-alpha. J Neurosci. 2015;35:8411\u201322.","journal-title":"J Neurosci"},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12974-017-0830-9","volume":"14","author":"VR Parillaud","year":"2017","unstructured":"Parillaud VR, Lornet G, Monnet Y, Privat AL, Haddad AT, Brochard V, Bekaert A, de Chanville CB, Hirsch EC, Combadiere C, et al. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. J Neuroinflammation. 2017;14:60.","journal-title":"J Neuroinflammation"},{"key":"1125_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/acn3.414","volume":"4","author":"DA Galloway","year":"2017","unstructured":"Galloway DA, Williams JB, Moore CS. Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation. Ann Clin Transl Neurol. 2017;4:381\u201391.","journal-title":"Ann Clin Transl Neurol"},{"key":"1125_CR51","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.1523\/JNEUROSCI.4099-08.2008","volume":"28","author":"MR Vargas","year":"2008","unstructured":"Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci. 2008;28:13574\u201381.","journal-title":"J Neurosci"},{"key":"1125_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2016.09.011","volume":"59","author":"E Hennessy","year":"2017","unstructured":"Hennessy E, Gormley S, Lopez-Rodriguez AB, Murray C, Murray C, Cunningham C. Systemic TNF-alpha produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration. Brain Behav Immun. 2017;59:233\u201344.","journal-title":"Brain Behav Immun"},{"key":"1125_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbi.2016.01.009","volume":"54","author":"MM Muccigrosso","year":"2016","unstructured":"Muccigrosso MM, Ford J, Benner B, Moussa D, Burnsides C, Fenn AM, Popovich PG, Lifshitz J, Walker FR, Eiferman DS, Godbout JP. Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge. Brain Behav Immun. 2016;54:95\u2013109.","journal-title":"Brain Behav Immun"},{"key":"1125_CR54","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","volume":"13","author":"AI Rojo","year":"2017","unstructured":"Rojo AI, Pajares M, Rada P, Nunez A, Nevado-Holgado AJ, Killik R, Van Leuven F, Ribe E, Lovestone S, Yamamoto M, Cuadrado A. NRF2 deficiency replicates transcriptomic changes in Alzheimer\u2019s patients and worsens APP and TAU pathology. Redox Biol. 2017;13:444\u201351.","journal-title":"Redox Biol"},{"key":"1125_CR55","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1093\/hmg\/ddx361","volume":"26","author":"C Branca","year":"2017","unstructured":"Branca C, Ferreira E, Nguyen TV, Doyle K, Caccamo A, Oddo S. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet. 2017;26:4823\u201335.","journal-title":"Hum Mol Genet"},{"key":"1125_CR56","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neurobiolaging.2014.09.004","volume":"36","author":"G Joshi","year":"2015","unstructured":"Joshi G, Gan KA, Johnson DA, Johnson JA. Increased Alzheimer\u2019s disease-like pathology in the APP\/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging. 2015;36:664\u201379.","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1125-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1125-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1125-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T20:04:53Z","timestamp":1553803493000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1125-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1125-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"12 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. This article does not contain any individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"100"}}